In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Center for Global Health

Page Options

  • Print This Page
  • Email This Document

NCI Partners in China

NCI Intramural and NCI-supported extramural researchers are working with several top institutions in China on collaborative projects, including:

Beijing Cancer Hospital, Peking University
中文 | English
NCI-supported researchers worked with Beijing Cancer Hospital on several projects including long-term follow up of participants from an intervention trial for gastric cancer.

Beijing Guang An Men Hospital, China Academy of Chinese Medical Sciences
中文 | English
NCI-supported researchers are working with scientists at Beijing Guang An Men Hospital to explore the anticancer activity of the Sheng Qi Formula (SQF). SQF is a mixture of herbs frequently used at Guang An Men Hospital to decrease the side effects of chemotherapy.

Cancer Institute/Hospital of the Chinese Academy of Medical Sciences
中文 | English
NCI-supported researchers work with the Cancer Institute/Hospital of the Chinese Academy of Medical Sciences (CICAMS) on a number of initiatives, including studies of nutrition intervention and risk factors contributing to high rates of esophageal cancer, a series of other studies to develop early detection and treatment methods for esophageal cancer and cervical cancer and its precursor lesions, a study of risk factors contributing to high rates of lung cancer in tin miners in Yunnan Province, and a study of women living in rural China to evaluate novel low-cost molecular HPV tests and strategies for cervical cancer screening.

Chinese Academy of Sciences
中文 | English
NCI scientists worked with researchers from an institute of the Chinese Academy of Sciences (CAS), the National Center for Nanoscience and Technology, China, together with scientists from the U.S. National Heart Lung Blood Institute (NHLBI) and the Food and Drug Administration (FDA) to explore the role of a gene SIRT1 in developing resistance to the chemotherapy drug cisplatin. A separate group of NCI-supported scientists are working with the CAS Kunming Institute of Botany to determine if compounds isolated from various plants in China have anticancer properties.

Chinese Center for Disease Control and Prevention (Chinese CDC)
中文 | English
NCI-supported researchers have conducted multiple studies in collaboration with the Chinese Center for Disease Control and Prevention (Chinese CDC), including:

  • Studies of blood cancer risk in benzene-exposed workers in China
  • Studies of lung cancer risk in non-smoking women residing in homes where smoky coal was burned in indoor unvented firepits for cooking
  • Investigations of tobacco use prevention programs in China
Chinese University of Hong Kong and Hong Kong Baptist University
中文 | English
中文 | English
NCI-supported investigators are systematically evaluating traditional Chinese medicine (TCM) botanicals for anticancer properties. This project is establishing a library of authenticated TCM botanical abstracts for scientific evaluation, creating a high-throughput and combinatorial screening core, and testing these compounds in relevant animal tumor models.

Fudan University Shanghai Cancer Center
中文 | English
NCI has supported researchers at the International Center of Traditional Chinese Medicine at the Fudan University Shanghai Cancer Center to investigate three aspects of TCM: 1) herbal and natural treatments that target cancer and related symptoms; 2) acupuncture for some side effects of cancer treatment; and 3) bio-behavioral effects of Qigong and other mind/body interventions.

Guangdong Poison Control Center
NCI researchers carried out two cross-sectional molecular epidemiology studies of early biologic effect biomarkers among workers exposed to trichloroethylene and formaldehyde in Guangdong Province and are continuing to analyze the biomarker and exposure assessment data.

Liver Cancer Institute of Fudan University
中文
NCI-supported researchers have worked with the Liver Cancer Institute of Fudan University, which is affiliated with Zhongshan Hospital, on the role of p53 mutations in liver carcinogenesis and more recently have shown that a specific pattern of microRNA expression is predictive of metastases and patient survival.

Shanghai Cancer Institute
中文 | English
NCI-supported researchers worked with the Shanghai Cancer Institute (SCI) to develop population cohorts that have been used in many studies, including identifying the impact of diet on cancer risk, genome wide association studies (GWAS), and measuring biomarkers that that may be important in cancer and other disease processes.

Sun Yat-sen University Cancer Center
中文 | English
NCI has supported a research collaboration to investigate causes that contribute to the high incidence of nasopharyngeal carcinoma observed in southern China.